---
title: "MiMedx Group (MDXG) Receives a Buy from Mizuho Securities"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/284897354.md"
description: "MiMedx Group (MDXG) received a Buy rating from Mizuho Securities, with a price target of $8.00, while shares closed at $3.36. Analyst Anthony Petrone has a 4.0% average return and a 45.55% success rate. The consensus rating for MiMedx is a Strong Buy, with an average price target of $6.83, indicating a 103.27% upside. Craig-Hallum also assigned a Buy rating with a $6.00 price target."
datetime: "2026-05-01T12:28:19.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/284897354.md)
  - [en](https://longbridge.com/en/news/284897354.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/284897354.md)
---

# MiMedx Group (MDXG) Receives a Buy from Mizuho Securities

In a report released yesterday, Anthony Petrone from Mizuho Securities maintained a Buy rating on MiMedx Group, with a price target of $8.00. The company’s shares closed yesterday at $3.36.

### Claim 55% Off TipRanks

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

Petrone covers the Healthcare sector, focusing on stocks such as Pulse Biosciences, Haemonetics, and Boston Scientific. According to TipRanks, Petrone has an average return of 4.0% and a 45.55% success rate on recommended stocks.

Currently, the analyst consensus on MiMedx Group is a Strong Buy with an average price target of $6.83, representing a 103.27% upside. In a report released yesterday, Craig-Hallum also assigned a Buy rating to the stock with a $6.00 price target.

### Related Stocks

- [MDXG.US](https://longbridge.com/en/quote/MDXG.US.md)
- [MFG.US](https://longbridge.com/en/quote/MFG.US.md)
- [PLSE.US](https://longbridge.com/en/quote/PLSE.US.md)
- [HAE.US](https://longbridge.com/en/quote/HAE.US.md)
- [BSX.US](https://longbridge.com/en/quote/BSX.US.md)
- [8411.JP](https://longbridge.com/en/quote/8411.JP.md)

## Related News & Research

- [23:01 ETINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MiMedx Group, Inc. - MDXG](https://longbridge.com/en/news/286499871.md)
- [Citizens Jmp Reaffirms "Market Outperform" Rating for MiMedx Group (NASDAQ:MDXG)](https://longbridge.com/en/news/283357487.md)
- [Do Wall Street Analysts Like Arch Capital Stock?](https://longbridge.com/en/news/286783105.md)
- [Jefferies Reaffirms Their Buy Rating on Devon Energy (DVN)](https://longbridge.com/en/news/286728558.md)
- [Why This Analyst Thinks Texas Instruments Stock Is on the Path to $1 Trillion](https://longbridge.com/en/news/286957345.md)